Gary Manchee

Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom.

Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom.

Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom.

Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom.

Pharmidex Pharmaceutical Services Ltd. develops medicines for central nervous system diseases. Its offers In Vitro Admet, Cerense-drug delivery, Bioanalysis and Metabolism, CNS solution, Biomaging, Pharmacokinetics, Physicochemical properties and Zebrafish. The company was founded by Alan Palmer and Mohammad Sadeghi Alavijeh in 2002 and is headquartered in London, the United Kingdom.